---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-26-001384"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2026-08-17T16:37:43+00:00"
generated_at: "2026-08-17T16:39:26.174832+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lexaria regains Nasdaq bid price compliance; hearing cancelled, stock remains listed

## Summary
- Received Nasdaq letter on Aug 17, 2026 confirming compliance with Rule 5550(a)(2) bid price requirement.
- Previously requested hearing before Nasdaq Hearings Advisor has been cancelled.
- Common stock (LEXX) continues trading on The Nasdaq Capital Market without interruption.

## SEC filing metadata
- accession: 0001640334-26-001384
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2026-08-17T16:37:43+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033426001384/0001640334-26-001384-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033426001384/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-26-001384
- JSON: https://secwatch.observer/filing/0001640334-26-001384.json
- Plain text: https://secwatch.observer/filing/0001640334-26-001384.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.